The current status, challenges, and future developments of new tuberculosis vaccines

Area of Science:

• Immunology
• Infectious Diseases
• Vaccinology

Background:

• Tuberculosis (TB), caused by Mycobacterium tuberculosis complex, is a leading global cause of death.
• The existing Bacillus Calmette-Guérin (BCG) vaccine offers limited protection against pulmonary TB in adults.
• There is a critical need for novel vaccines to combat TB effectively.

Purpose of the Study:

• To review the innate and adaptive immune responses during Mycobacterium tuberculosis infection.
• To present current advancements and challenges in the development of novel TB vaccines.
• To provide insights for creating safer and more effective TB vaccines.

Main Methods:

• Literature review of preclinical and clinical studies on TB vaccines.
• Analysis of immune responses to Mycobacterium tuberculosis infection.
• Synthesis of current research on vaccine development.

Main Results:

• The BCG vaccine's ineffectiveness necessitates new vaccine development.
• Understanding immune responses is key to designing better vaccines.
• Several novel vaccine candidates are in various stages of development.

Conclusions:

• Novel vaccines are essential for TB prevention and control.
• Further research into immune mechanisms and vaccine technologies is required.
• This review offers a foundation for future TB vaccine innovation.